Related Experiment Videos

[Prognosis of life in polymyositis/dermatomyositis]

K Murabayashi1, E Saito, S Okada

  • 1Fourth Department of Internal Medicine, Ohashi Hospital, Toho University, Tokyo.

Ryumachi. [Rheumatism]
|August 1, 1991
PubMed

Insights

Polymyositis and dermatomyositis (PM/DM) patients face significant mortality, often from respiratory or cardiac issues. Acute onset, fever, and lung fibrosis are key risk factors impacting survival in these inflammatory myopathies.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Cardiology

Context:

  • Polymyositis and dermatomyositis (PM/DM) are inflammatory myopathies with substantial patient mortality.
  • Limited research precisely details causes of death and associated risk factors in PM/DM.

Purpose:

  • To evaluate the prognosis, causes of death, and risk factors for mortality in adult patients with PM/DM.
  • To identify clinical manifestations associated with increased risk of death.

Summary:

  • Retrospective review of 76 adult PM/DM patients.
  • Five-year survival rate was 69.7% in patients without malignancy.
  • Respiratory failure (46%) and cardiac involvement (37%) were leading causes of death in non-malignant cases.
  • Acute interstitial pneumonitis presented rapidly, leading to death within 4 months.
  • Identified risk factors for mortality include acute onset, fever, arthritis, hypergammaglobulinemia, elevated ESR, lung fibrosis, and heart involvement.

Impact:

  • Provides critical insights into PM/DM mortality patterns and survival rates.
  • Highlights the importance of monitoring respiratory and cardiac function in PM/DM patients.
  • Informs clinical practice for risk stratification and early intervention strategies to improve PM/DM patient outcomes.

Related Concept Videos